TXG - 10X Genomics Inc

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and Asia Pacific. The company is headquartered in Pleasanton, California.

52W High

$24.38

52W Low

$6.78

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

2.00

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

196.08

EV/EBITDA (<8 favorable)

-40.69

EV/Revenue (<3 favorable)

2.14

P/S (TTM) (<3 favorable)

2.70

P/B (<3 favorable)

2.25

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

1.86%

Institutions (25–75% balanced)

104.63%

Shares Outstanding

114,411,000

Float

112,351,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

644,466,000

Gross Profit (TTM)

448,277,000

EPS (TTM)

-0.70

Profit Margin (>10% good)

-0.13%

Operating Margin (TTM) (higher better)

-0.03%

ROE (TTM) (>15% strong)

-0.11%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.13

Momentum

Bearish momentum

Value

0.2644

0.2505

Trend

Rising

Signal Cross

No cross

As of

Sep. 05, 2025